bf/NASDAQ:ONTX_icon.jpeg

COM:ONCONOVA

Onconova Therapeutics, Inc.

  • Stock

USD

Last Close

1.00

02/04 20:00

Market Cap

20.90M

Beta: -

Volume Today

1.25M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.05
-
0.02
62.61%
0.49
2,791.30%
0.24
51.15%
0.16
33.78%
0.07
56.65%
0.09
34.58%
0.01
87.47%
0.00
64.75%
0.01
40.91%
0.01
73.57%
cash per share
21.24K
-
4.53K
78.68%
1.96K
56.74%
1.09K
44.48%
100.60
90.75%
61.72
38.64%
23.70
61.61%
1.64
93.08%
3.27
99.52%
1.85
43.34%
0.99
46.48%
company equity multiplier
1.31
-
2.08
59.13%
2.34
12.55%
5.41
130.85%
-0.43
107.88%
3.33
881.22%
2.05
38.52%
3.24
58.23%
1.20
62.83%
1.39
15.62%
2.13
52.82%
days of inventory outstanding
days of payables outstanding
days of sales outstanding
47.92
-
2.04
95.74%
27.36
1,241.21%
10.40
61.98%
16.39
57.51%
58.46
256.79%
45.22
22.65%
46.84
3.57%
29.07
37.93%
dividend yield
ebit per revenue
-13.09
-
-79.68
508.66%
-2.09
97.37%
-4.27
104.25%
-32.70
665.17%
-18.96
42.03%
-9.94
47.57%
-108.19
988.48%
-72.99
32.54%
-86.85
18.98%
-89.81
3.42%
ebt per ebit
1.00
-
1.00
0.21%
1.00
0.10%
0.83
17.21%
0.94
12.84%
0.88
5.73%
0.99
12.31%
1.01
1.60%
0.98
2.64%
0.97
1.39%
0.93
3.39%
effective tax rate
-0.01
-
-0.00
95.75%
-0.00
123.71%
-0.00
6.89%
-0.00
24.21%
0.01
1,218.52%
-0.00
107.70%
-0.00
65.82%
0.02
13,133.25%
0.03
68.68%
enterprise value multiple
-0.99
-
-0.43
56.20%
-0.09
80.37%
0.41
581.66%
-0.35
184.37%
0.33
195.97%
0.79
138.65%
-2.53
419.33%
0.72
128.52%
1.28
77.51%
0.25
80.13%
fixed asset turnover
7.59
-
1.90
74.91%
46.19
2,325.16%
36.49
21.01%
12.30
66.30%
136.44
1,009.59%
43.66
68.00%
4.44
89.83%
5.95
33.88%
9.42
58.33%
10.27
9.09%
free cash flow per share
-13.17K
-
-6.01K
54.32%
-3.09K
48.61%
-803.75
74.00%
-595.49
25.91%
-82.55
86.14%
-21.78
73.62%
-1.99
90.86%
-1.16
41.83%
-0.78
32.69%
-0.86
9.72%
gross profit margin
1
-
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
interest coverage
-15.56K
-
-31.87K
104.89%
1.40K
-
inventory turnover
long term debt to capitalization
net income per ebt
1.01
-
1.00
0.82%
1.00
0.03%
1.00
0.19%
1.00
0.02%
1.00
0.14%
1.00
0.14%
1.00
0.03%
0.98
2.09%
0.97
1.45%
1
3.62%
net profit margin
-13.16
-
-79.60
504.94%
-2.09
97.37%
-3.55
69.42%
-30.61
763.26%
-16.75
45.27%
-9.85
41.20%
-108.90
1,005.61%
-70.04
35.69%
-80.98
15.62%
-83.84
3.54%
operating cash flow per share
-13.04K
-
-5.99K
54.05%
-3.09K
48.40%
-803.75
74.00%
-595.49
25.91%
-82.55
86.14%
-21.72
73.69%
-1.99
90.84%
-1.16
41.79%
-0.78
32.69%
-0.85
9.63%
operating profit margin
-13.09
-
-79.68
508.66%
-2.09
97.37%
-4.27
104.25%
-32.70
665.17%
-18.96
42.03%
-9.94
47.57%
-108.19
988.48%
-72.99
32.54%
-86.85
18.98%
-89.81
3.42%
payables turnover
pretax profit margin
-13.07
-
-79.72
509.95%
-2.10
97.37%
-3.54
69.10%
-30.60
763.41%
-16.72
45.35%
-9.85
41.12%
-108.89
1,005.95%
-71.52
34.32%
-83.91
17.33%
-83.84
0.08%
price fair value
1.51
-
3.13
107.07%
2.18
30.36%
2.34
7.24%
-1.15
149.38%
1.62
239.88%
0.47
70.76%
13.25
2,704.81%
0.93
92.97%
0.48
48.42%
1.47
205.45%
receivables turnover
7.62
-
178.90
2,248.73%
13.34
92.54%
35.09
163.03%
22.28
36.51%
6.24
71.97%
8.07
29.28%
7.79
3.45%
12.56
61.11%
return on assets
-0.59
-
-1.35
126.18%
-1.02
23.97%
-0.85
17.23%
-4.84
471.61%
-1.15
76.28%
-0.91
20.87%
-1.26
38.58%
-0.29
77.33%
-0.46
62.92%
-0.84
79.71%
return on capital employed
-0.66
-
-1.72
161.97%
-1.51
11.97%
-1.81
19.81%
5.15
384.07%
-2.45
147.66%
-1.41
42.53%
-2.51
77.79%
-0.33
86.68%
-0.63
87.49%
-1.51
140.64%
return on equity
-0.78
-
-2.80
259.93%
-2.40
14.43%
-4.58
91.06%
2.06
145.02%
-3.82
285.32%
-1.86
51.35%
-4.07
119.28%
-0.34
91.58%
-0.65
88.37%
-1.78
174.64%
total debt to capitalization
0.06
-
0.20
219.62%
0.27
33.95%
0.49
81.98%
0.44
-

All numbers in USD (except ratios and percentages)